Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HIV-associated lipodystrophy syndrome.

R B Qaqish1, E Fisher, J Rublein

  • 1Department of Pharmacy, University of North Carolina Hospitals and Clinics, Chapel Hill, USA.

Pharmacotherapy
|January 21, 2000
PubMed
Summary

Highly active antiretroviral therapy (HAART) improves survival for HIV-1 patients but can cause metabolic issues like lipodystrophy. This syndrome involves changes in lipids, diabetes, and fat distribution, potentially linked to specific HIV drugs and infection duration.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Case of Complete Inversion of the Uterus.

Illinois medical and surgical journal·2023
Same author

The effect of citalopram treatment on amyloid-β precursor protein processing and oxidative stress in human hNSC-derived neurons.

Translational psychiatry·2022
Same author

Patterning Chronic Active Demyelination in Slowly Expanding/Evolving White Matter MS Lesions.

AJNR. American journal of neuroradiology·2020
Same author

The ups and downs of low-carbohydrate diets in the management of Type 1 diabetes: a review of clinical outcomes.

Diabetic medicine : a journal of the British Diabetic Association·2018
Same author

Legislation of direct-to-consumer genetic testing in Europe: a fragmented regulatory landscape.

Journal of community genetics·2017
Same author

Great Expectations: HIV Risk Behaviors and Misperceptions of Low HIV Risk among Incarcerated Men.

AIDS and behavior·2017

Area of Science:

  • Infectious Diseases
  • Endocrinology
  • Pharmacology

Background:

  • Highly active antiretroviral therapy (HAART) significantly improves survival for individuals with human immunodeficiency virus-1 (HIV-1).
  • HAART and prophylactic treatments for opportunistic infections have led to increased longevity in HIV-1 patients.

Purpose of the Study:

  • To investigate the adverse metabolic and physical changes associated with HAART.
  • To identify the contributing factors to HIV-associated lipodystrophy syndrome.

Main Methods:

  • Review of adverse effects linked to HAART.
  • Analysis of potential associations between specific drug classes and syndrome development.
  • Consideration of HIV-1 infection duration as a factor.

Related Experiment Videos

Main Results:

  • Adverse effects of HAART include significant alterations in lipid profiles.
  • Development of diabetes mellitus and fat redistribution are key features of the syndrome.
  • Protease inhibitors were initially implicated, with recent evidence suggesting nucleoside reverse transcriptase inhibitors also play a role.

Conclusions:

  • HIV-associated lipodystrophy syndrome is a significant concern with HAART.
  • Both specific antiretroviral drugs and the duration of HIV-1 infection contribute to the syndrome's development.
  • Further research is needed to fully elucidate the complex etiology of HIV-associated lipodystrophy.